Unfortunately, in breast cancer cells, we could not observe how the ectopic expression of AEG-1 activated those signaling molecules, and thus we were unable to examine how NCL regulates AEG-1-mediated signaling pathways. This evidence concerns the gene NUCLEOLIN and breast carcinoma.